These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26571766)

  • 1. [The Cutting-edge of Medicine; Genetic alterations and their prognostic implications in acute myeloid leukemia].
    Kiyoi H
    Nihon Naika Gakkai Zasshi; 2015 Jun; 104(6):1180-8. PubMed ID: 26571766
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.
    Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L
    J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
    Hájková H; Marková J; Haškovec C; Sárová I; Fuchs O; Kostečka A; Cetkovský P; Michalová K; Schwarz J
    Leuk Res; 2012 Sep; 36(9):1128-33. PubMed ID: 22749068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing DNA methylation-based prognostic biomarkers of acute myeloid leukemia.
    Gao C; Zhuang J; Zhou C; Liu L; Liu C; Li H; Zhao M; Liu G; Sun C
    J Cell Biochem; 2018 Dec; 119(12):10041-10050. PubMed ID: 30171717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.
    Ryotokuji T; Yamaguchi H; Ueki T; Usuki K; Kurosawa S; Kobayashi Y; Kawata E; Tajika K; Gomi S; Kanda J; Kobayashi A; Omori I; Marumo A; Fujiwara Y; Yui S; Terada K; Fukunaga K; Hirakawa T; Arai K; Kitano T; Kosaka F; Tamai H; Nakayama K; Wakita S; Fukuda T; Inokuchi K
    Haematologica; 2016 Sep; 101(9):1074-81. PubMed ID: 27247325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics in AML.
    Melnick AM
    Best Pract Res Clin Haematol; 2010 Dec; 23(4):463-8. PubMed ID: 21130408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation status of the promoter region of the human frizzled 9 gene in acute myeloid leukemia.
    Zhang Y; Jiang Q; Kong X; Yang L; Hu W; Lv C; Li Y
    Mol Med Rep; 2016 Aug; 14(2):1339-44. PubMed ID: 27314612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses.
    Shivarov V; Dolnik A; Lang KM; Krönke J; Kuchenbauer F; Paschka P; Gaidzik VI; Döhner H; Schlenk RF; Döhner K; Bullinger L
    Haematologica; 2016 Nov; 101(11):e454-e456. PubMed ID: 27470604
    [No Abstract]   [Full Text] [Related]  

  • 9. The increasing genomic complexity of acute myeloid leukemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2014; 27(3-4):209-13. PubMed ID: 25455268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PcG methylation of the HIST1 cluster defines an epigenetic marker of acute myeloid leukemia.
    Tiberi G; Pekowska A; Oudin C; Ivey A; Autret A; Prebet T; Koubi M; Lembo F; Mozziconacci MJ; Bidaut G; Chabannon C; Grimwade D; Vey N; Spicuglia S; Calmels B; Duprez E
    Leukemia; 2015 May; 29(5):1202-6. PubMed ID: 25482132
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular biomarkers in acute myeloid leukemia.
    Prada-Arismendy J; Arroyave JC; Röthlisberger S
    Blood Rev; 2017 Jan; 31(1):63-76. PubMed ID: 27639498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic signatures as prognostic tools in acute myeloid leukemia and myelodysplastic syndromes.
    Christopeit M; Bartholdy B
    Epigenomics; 2014; 6(4):371-4. PubMed ID: 25333846
    [No Abstract]   [Full Text] [Related]  

  • 14. DNMT3A in Leukemia.
    Brunetti L; Gundry MC; Goodell MA
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 28003281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Li ZH; Wang NN; Fang F; Xu LX; Pan J
    Leuk Lymphoma; 2015; 56(10):2931-44. PubMed ID: 25629980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of miRNA genes in acute leukemia.
    Agirre X; Martínez-Climent JÁ; Odero MD; Prósper F
    Leukemia; 2012 Mar; 26(3):395-403. PubMed ID: 22143672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights.
    Claus R; Plass C; Armstrong SA; Bullinger L
    Future Oncol; 2010 Sep; 6(9):1415-31. PubMed ID: 20919827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukemia with DNMT3A mutations.
    Li Y; Zhu B
    Leuk Lymphoma; 2014 Sep; 55(9):2002-12. PubMed ID: 24283755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
    J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia.
    Claus R; Pfeifer D; Almstedt M; Zucknick M; Hackanson B; Plass C; Lübbert M
    Leuk Res; 2013 Feb; 37(2):190-6. PubMed ID: 23158571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.